Literature DB >> 15257313

Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma.

Mónica García-Cosío1, Almudena Santón, Paloma Martín, Natalia Camarasa, Carlos Montalbán, Juan F García, Carmen Bellas.   

Abstract

Hodgkin's lymphoma can be considered in most cases a B-cell lymphoma due to the presence of potentially functional immunoglobulin (Ig) gene rearrangements in the neoplastic cells. In contrast to lymphocyte-predominant Hodgkin's lymphoma, Hodgkin/Reed-Sternberg (HRS) cells from classical Hodgkin's lymphoma have low frequency of B-cell marker expression and lack Ig light and Ig heavy messenger RNA. Recent studies have shown transcription machinery deficiency in Hodgkin's lymphoma caused by an absence of the transcription factors OCT.1, OCT.2 and/or BOB.1. By using the tissue microarray technique, we have performed an immunohistochemical study of OCT.1, OCT.2 and BOB.1 in 325 classical Hodgkin's lymphoma cases. The results have been correlated with the expression of the B-cell markers CD20, CD79a, B-cell-specific activator protein (BSAP) and MUM.1, the presence of Epstein-Barr virus and the histological subtype. The percentage of CD20 and CD79a positivity was low (18 and 18%, respectively), whereas MUM.1 and BSAP were positive in the majority of cases. Considering the positive cases with independence of the intensity of staining, 62% of them expressed OCT.2, 59% OCT.1 and 37% BOB.1. Nevertheless, when we considered only the strongly positive cases, the results were similar to those previously described by others. No statistical association was found between the transcription factor expression, histological subtype and Epstein-Barr virus presence. To our knowledge, this is the largest series of classical Hodgkin's lymphoma cases in which the expression of transcription factors has been studied. We have found a notorious percentage of cases displaying weak positivity for OCT.2 and BOB.1 factors in HRS cells. We propose that other mechanisms different from the absence of transcription factors OCT.2 and BOB.1 might be involved in the control of Ig transcription and B lineage in classical Hodgkin's lymphoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257313     DOI: 10.1038/modpathol.3800227

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  13 in total

Review 1.  The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks.

Authors:  Karina Vázquez-Arreguín; Dean Tantin
Journal:  Biochim Biophys Acta       Date:  2016-02-10

Review 2.  The role of Pax5 in leukemia: diagnosis and prognosis significance.

Authors:  Mohammad Shahjahani; Fatemeh Norozi; Ahmad Ahmadzadeh; Saeid Shahrabi; Farzaneh Tavakoli; Ali Amin Asnafi; Najmaldin Saki
Journal:  Med Oncol       Date:  2014-11-27       Impact factor: 3.064

3.  Peak-valley-peak pattern of histone modifications delineates active regulatory elements and their directionality.

Authors:  Sachin Pundhir; Frederik O Bagger; Felicia B Lauridsen; Nicolas Rapin; Bo T Porse
Journal:  Nucleic Acids Res       Date:  2016-04-19       Impact factor: 16.971

4.  Primary gastric Hodgkin's lymphoma expressing a B-Cell profile including Oct-2 and Bob-1 proteins.

Authors:  Makoto Saito; Shinya Tanaka; Akio Mori; Nobuyasu Toyoshima; Tatsuro Irie; Masanobu Morioka
Journal:  Int J Hematol       Date:  2007-06       Impact factor: 2.490

5.  Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival.

Authors:  Girish Venkataraman; Joo Y Song; Alexandar Tzankov; Stephan Dirnhofer; Georg Heinze; Maria Kohl; Alexandra Traverse-Glehen; Franziska C Eberle; Jeffrey C Hanson; Mark A Raffeld; Stefania Pittaluga; Elaine S Jaffe
Journal:  Blood       Date:  2013-01-10       Impact factor: 22.113

6.  B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma without mediastinal disease: mimicking nodular sclerosis classical Hodgkin lymphoma.

Authors:  Noriko Iwaki; Yasuharu Sato; Toshiro Kurokawa; Yoshinobu Maeda; Kyotaro Ohno; Mai Takeuchi; Katsuyoshi Takata; Yorihisa Orita; Shinji Nakao; Tadashi Yoshino
Journal:  Med Mol Morphol       Date:  2013-03-20       Impact factor: 2.309

7.  CD20 Over-Expression in Hodgkin-Reed-Sternberg Cells of Classical Hodgkin Lymphoma: the Neglected Quest.

Authors:  Daniel Benharroch; Karen Nalbandyan; Irina Lazarev
Journal:  J Cancer       Date:  2015-09-15       Impact factor: 4.207

8.  BOB.1-positive Classical Hodgkin's Lymphoma Carries Hypermethylation of Its Promoter as Epigenetic Marker of Gene-silencing Memory.

Authors:  Takafumi Watanabe; Riko Kitazawa; Yosuke Mizuno; Natsumi Kuwahara; Chizu Ito; Atsuro Sugita; Ryuma Haraguchi; Sohei Kitazawa
Journal:  Acta Histochem Cytochem       Date:  2014-06-26       Impact factor: 1.938

9.  POU2F2-oriented network promotes human gastric cancer metastasis.

Authors:  Si-Meng Wang; Jun Tie; Wen-Lan Wang; Si-Jun Hu; Ji-Peng Yin; Xiao-Fang Yi; Zu-Hong Tian; Xiang-Yuan Zhang; Meng-Bin Li; Zeng-Shan Li; Yong-Zhan Nie; Kai-Chun Wu; Dai-Ming Fan
Journal:  Gut       Date:  2015-05-27       Impact factor: 23.059

10.  Bob-1 is expressed in classic Hodgkin lymphoma.

Authors:  Howayda S Abd El All
Journal:  Diagn Pathol       Date:  2007-03-08       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.